---
title: "12 Health Care Stocks Moving In Monday's After-Market Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/291847958.md"
description: "In Monday's after-market session, healthcare stocks showed significant volatility. Vicore Pharma surged 149.8% to $42.47, while Crinetics Pharmaceuticals rose 99.85% to $84.0. Other gainers included Aligos Therapeutics (+19.65%) and Zhengye Biotechnology (+9.98%). Conversely, Celularity declined 11.3%, followed by drops in RxSight (-10.66%), China Pharma Holding (-10.43%), MaxCyte (-9.45%), Jasper Therapeutics (-8.82%), and Innovative Eyewear (-7.26%)."
datetime: "2026-07-06T21:05:35.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/291847958.md)
  - [en](https://longbridge.com/en/news/291847958.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/291847958.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's After-Market Session

### Gainers

-   **Vicore Pharma Holding** (NASDAQ:VCRE) stock rose 149.8% to $42.47 during Monday's after-market session.
-   **Crinetics Pharmaceuticals** (NASDAQ:CRNX) stock moved upwards by 99.85% to $84.0. The company's market cap stands at $4.4 billion.
-   **Aligos Therapeutics** (NASDAQ:ALGS) shares moved upwards by 19.65% to $7.0. The market value of their outstanding shares is at $34.5 million.
-   **Zhengye Biotechnology** (NASDAQ:ZYBT) shares rose 9.98% to $0.72. The company's market cap stands at $30.6 million.
-   **Aktis Oncology** (NASDAQ:AKTS) shares moved upwards by 6.15% to $28.2. The market value of their outstanding shares is at $1.7 billion.
-   **Bluejay Diagnostics** (NASDAQ:BJDX) stock rose 6.03% to $1.23. The market value of their outstanding shares is at $1.1 million.

### Losers

-   **Celularity** (NASDAQ:CELU) stock declined by 11.3% to $0.71 during Monday's after-market session. The company's market cap stands at $17.6 million.
-   **RxSight** (NASDAQ:RXST) stock fell 10.66% to $5.02. The market value of their outstanding shares is at $232.2 million.
-   **China Pharma Holding** (AMEX:CPHI) stock decreased by 10.43% to $0.61. The company's market cap stands at $29.0 million.
-   **MaxCyte** (NASDAQ:MXCT) stock fell 9.45% to $1.15. The market value of their outstanding shares is at $130.1 million.
-   **Jasper Therapeutics** (NASDAQ:JSPR) shares decreased by 8.82% to $0.42. The company's market cap stands at $11.9 million.
-   **Innovative Eyewear** (NASDAQ:LUCY) stock decreased by 7.26% to $1.15. The company's market cap stands at $4.8 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [RXST.US](https://longbridge.com/en/quote/RXST.US.md)
- [LUCY.US](https://longbridge.com/en/quote/LUCY.US.md)
- [CELUW.US](https://longbridge.com/en/quote/CELUW.US.md)
- [MXCT.US](https://longbridge.com/en/quote/MXCT.US.md)
- [ZYBT.US](https://longbridge.com/en/quote/ZYBT.US.md)
- [ALGS.US](https://longbridge.com/en/quote/ALGS.US.md)
- [CPHI.US](https://longbridge.com/en/quote/CPHI.US.md)
- [CELU.US](https://longbridge.com/en/quote/CELU.US.md)
- [VCRE.US](https://longbridge.com/en/quote/VCRE.US.md)
- [JSPR.US](https://longbridge.com/en/quote/JSPR.US.md)
- [LUCYW.US](https://longbridge.com/en/quote/LUCYW.US.md)
- [CRNX.US](https://longbridge.com/en/quote/CRNX.US.md)
- [AKTS.US](https://longbridge.com/en/quote/AKTS.US.md)
- [BJDX.US](https://longbridge.com/en/quote/BJDX.US.md)

## Related News & Research

- [Bank of America Corp DE Sells 85,189 Shares of Crinetics Pharmaceuticals, Inc. $CRNX](https://longbridge.com/en/news/296069006.md)
- [Nexgel’s Celularity Deal: Execution, Integration, and Profitability Risks from $13.3 Million Biomaterials Acquisition](https://longbridge.com/en/news/296183101.md)
- [Crinetics supplements proxy disclosures for Vertex USD 85-per-share buyout after shareholder suits](https://longbridge.com/en/news/296395094.md)
- [Jasper Therapeutics Q2 loss per share beats estimates, raises $132 mln](https://longbridge.com/en/news/295952283.md)
- [Jasper Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update | JSPR Stock News](https://longbridge.com/en/news/295951622.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**